Inclusion body myositis and myopathies

@article{Sivakumar2002InclusionBM,
  title={Inclusion body myositis and myopathies},
  author={Kumaraswamy Sivakumar and Marinos C. Dalakas},
  journal={Journal of the Neurological Sciences},
  year={2002},
  volume={199},
  pages={S49-S51}
}
View on Elsevier
europepmc.org
315 Citations
Highly Influential Citations
19
Background Citations
81
Methods Citations
38
Results Citations
2

315 Citations

Citation Type

Citation Type

Sporadic inclusion body myositis and hereditary inclusion body myopathy.
TLDR
An awareness of the clinical phenotype and of the electrodiagnostic and histopathologic features should lead to improved recognition, and should minimize confusion with polymyositis, motor neuron disease, and other neuromuscular disorders.
Familial Inclusion Body Myositis (FIBM): Update
TLDR
The combination of clinical, histological, immunopathological and immunogenetic features indicates that these patients have a disease identical to sporadic inclusion body myositis.
Emerging therapeutic options for sporadic inclusion body myositis
TLDR
This review discusses the clinical presentation of inclusion body myositis and the current efforts in diagnosis, and focuses on the current state of research for both nonpharmacological and pharmacological treatment options for this patient group.
Inclusion body myositis: genetic factors, aberrant protein expression, and autoimmunity
TLDR
This review summarizes the new information on genetic factors, abnormal protein expression and inflammation, which provides a basis for linking the different typical morphologic features of s-IBM to a cascade of pathogenic events.
Inclusion body myositis: clinical review and current practice
TLDR
The purpose of this review is to provide an update on the scientific developments in IBM with particular emphasis on current and future clinical trials.
[Inflammatory myopathies. Dermatomyositis, polymyositis, and inclusion body myositis].
CURRENT ESSENTIALS IN INFLAMMATORY MYOPATHIES
TLDR
While DM, PM and NM respond well to immunosuppressive treatment, IBM is usually resistant to immunotherapy and this review aims to give a concise overview and provide guidance for general management of myositis.
Myouclear Breakdown in Sporadic Inclusion Body Myositis
TLDR
Figures that show abnormal localization of nuclear proteins associated with MAP kinase in s-IBM muscle fibers suggest that inhibition of nuclear transport during myogenesis is suggested and the theory that nuclear damage is closely associated with its etiology is supported.
Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
TLDR
This review summarizes the current understanding of the genetic contributions to sIBM and provides some insights for future research in this mysterious disease with the advantage of the rapid development of advanced genetic technology.
Oculopharyngeal myopathy with inflammation and calcinosis: an unusual phenotype
The case is reported of a patient with progressive proximal and distal weakness, dysphagia, respiratory weakness, calcifications, ptosis and ophthalmoparesis with inflammation, rimmed vacuoles and…
...
...